US to Resume J&J COVID Vaccinations Despite Rare Clot RiskUS to Resume J&J COVID Vaccinations Despite Rare Clot RiskU.S. health officials have lifted an 11-day pause on Johnson & Johnson vaccinations following a recommendation by an expert panel.Associated PressAssociated PressBrandon ComeauxBrandon Comeaux
